Advanced Non-hematologic Malignancies
4 clinical trials · Condition
◉ Watch Advanced Non-hematologic Malignancies
| Record | Firm | Date |
|---|---|---|
| Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies (NCT00948467) | Millennium Pharmaceuticals, Inc. | 2009-12-01 |
| A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors (NCT00915278) | Pfizer | 2009-09-01 |
| A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies (NCT00830869) | Millennium Pharmaceuticals, Inc. | 2009-03-02 |
| CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies (NCT01653158) | Pfizer | 2005-03-01 |
Track Advanced Non-hematologic Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.